Edesa Biotech (EDSA) Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization
Market fluctuations in the share price of Edesa Biotech, Inc. (EDSA), a developer of immunological agents, show an EV/EBITDA ratio of 0.00. Process optimization is being driven by the implementation of robotic screening and data analysis software. However, the business relies on the success of EB05 trials while facing a lack of sales and patent threats. Pressure from global behemoths developing more efficient biosimilars is acutely felt.
edesabiotech.com - analytical breakdowns and key metrics (EDSA)
- current price and projected stock value:
- market capitalization details:
- book value of equity indicators:
- debt level and financial liquidity data:
- business earnings and investment ratios data:
EDSA - Company Net Income|Expected Profit Edesa Biotech, Inc.|EDSA - Business Payback Period|Forward P/E Multiple Edesa Biotech, Inc.|EDSA - PEG Multiple|Enterprise Value to EBITDA Ratio Edesa Biotech Corp|EDSA - Income before deduction of interest, taxes and amortization|Net earnings per share (EPS TTM) Edesa Biotech|EDSA - Earnings per share for the last twelve months|Quarterly EPS earnings growth edesabiotech.com|EDSA - Expected net earnings per share growth this year|Net earnings per share growth forecast for next year Edesa Biotech, Inc.
Initial company analysis:Edesa EDSA
This ratio correlates the total enterprise value, including net debt, with its operating profit before taxes and depreciation, allowing for an assessment of the real value of assets regardless of the financing structure. For Edesa Biotech, Inc. (EDSA), which utilizes external CDMO bio-factories instead of costly in-house facilities, the company's current EV/EBITDA multiple serves as an indicator of capital management efficiency and the absence of excessive capital expenditures.
Competitor analysis
EV/EBITDA Multiple ARGX (Argenx)|Total Company Value to Operating Income Before Depreciation Ratio BioNTech Pharma (BNTX)|ABVX - Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization|admabiologics.com (ADMA) - Enterprise Value to EBITDA Ratio|Protagonist (PTGX) - Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization|Enterprise Value to EBITDA Ratio Immunovant Inc|Enterprise Value to EBITDA Ratio KNSA|EV/EBITDA Multiple Grifols Biemat|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization Adaptive Biotechnologies (ADPT)|celldex.com - Enterprise Value to Operating Income Before Depreciation|EV/EBITDA Multiple AUPH (Aurinia Pharmaceuticals Inc.)|BioCryst Pharmaceuticals, Inc. (BCRX) - Company Value to EBITDA|Vera Pharma - EV/EBITDA Multiple|Company Value to EBITDA Dianthus Corp|PHVS: EV/EBITDA Multiple|Enterprise Value to Operating Income Before Depreciation ABCL|TRML (Tourmaline Bio) - EV/EBITDA Multiple|Company Value to EBITDA Precigen Inc PGEN|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization Pharming (PHAR)|Total Company Value to Operating Income Before Depreciation Ratio Nektar Corp|EV/EBITDA Multiple UPB (Upstream Bio Inc)|EV/EBITDA Multiple zenasbio.com ZBIO|IMNM: Enterprise Value to EBITDA Ratio|Business Value to Operating Income Before Depreciation GOSS (Gossamer Bio Inc)|KALV: EV/EBITDA Multiple|SEPN (Septerna Pharma) - Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization|PVLA (Pieris Pharmaceuticals) - EV/EBITDA Multiple|savarapharma.com (SVRA) - Total Company Value to Operating Income Before Depreciation Ratio|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization Rigel Pharmaceuticals, Inc. (RIGL)|ANAB - Company Value to EBITDA|Astria Pharma - Enterprise Value to EBITDA Ratio|Enterprise Value to Operating Income Before Depreciation Ratio ENGN (enGene Corp)|RAPT Therapeutics - EV/EBITDA Multiple|Company Value to EBITDA Aerovate Therapeutics Inc|ACRS: EV/EBITDA Multiple|Enterprise Value to EBITDA Ratio Kyverna Therapeutics Inc.|TLSA (Tiziana Life Sciences PLC) - EV/EBITDA Multiple|CABA: Business Value to Operating Income Before Depreciation|Enterprise Value to EBITDA Ratio VTYX (Ventyx Biosciences)|THTX (theratech.com) - Business Value to Operating Income Before Depreciation|EV/EBITDA Multiple AVTX (Avalo Therapeutics)|Total Company Value to Operating Income Before Depreciation Ratio Eledon Pharmaceuticals Inc. (ELDN)|AGEN - Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization|CLYM (Climb Bio, Inc) - Enterprise Value to Operating Income Before Depreciation|ZURA: EV/EBITDA Multiple|Enterprise Value to EBITDA Ratio atyrpharma.com|Enterprise Value to EBITDA Ratio ADAG|Ikena Oncology, Inc. (IMA) - Total Company Value to Operating Income Before Depreciation Ratio|EV/EBITDA Multiple STTK|EQ - Company Value to EBITDA|EV/EBITDA Multiple CNTB (Connect Biopharma Holdings Limited)|IMUX: Enterprise Value to Operating Income Before Depreciation|ATRA - Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization|Total Company Value to Operating Income Before Depreciation Ratio InflaRx N.V. IFRX|XFOR: EV/EBITDA Multiple|Adicet Bio, Inc. (ACET) - EV/EBITDA Multiple|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization Celularity Inc|inmunebio.com - Company Value to Operating Income Before Depreciation Ratio|EV/EBITDA Multiple BRNS|KZR (Kezar Life Sciences Inc.) - Business Value to Operating Income Before Depreciation|EV/EBITDA Multiple SABS (SAB Biotherapeutics, Inc)|EV/EBITDA Multiple Akari Therapeutics, Plc AKTX|ENLV - Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization|Business Value to Operating Income Before Depreciation QTTB (Q32 Bio Inc.)|GeoVax (GOVX) - Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization|Enterprise Value to EBITDA Ratio iBio Inc|CARM (Carisma Therapeutics Inc) - EV/EBITDA Multiple|EV/EBITDA Multiple XTL Bio|Enterprise Value to EBITDA Ratio BOLT (Bolt Biotherapeutics)|HCWB (hcwbiologics.com) - Business Value to Operating Income Before Depreciation|EV/EBITDA Multiple APVO (Aptevo Therapeutics Inc.)|Total Company Value to Operating Income Before Depreciation Ratio aimimmuno.com (AIM)|ADTX - Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization|GRI Bio Corporation (GRI) - Enterprise Value to EBITDA Ratio|XORTX Therapeutics Inc. (XRTX) - Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization|Enterprise Value to EBITDA Ratio reshapelifesciences.com|Enterprise Value to EBITDA Ratio REVB|EV/EBITDA Multiple Indaptus Therapeutics Inc|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization Scinai (SCNI)|calcimedica.com - Enterprise Value to Operating Income Before Depreciation|EV/EBITDA Multiple AFMD (Affimed N.V.)|Allakos Inc (ALLK) - Company Value to EBITDA|HOOKIPA - EV/EBITDA Multiple|Company Value to EBITDA IGM Biosciences, Inc.|ITOS: EV/EBITDA Multiple|Enterprise Value to Operating Income Before Depreciation OCEA|TCBP (TC Biopharm) - EV/EBITDA Multiple|Company Value to EBITDA thirdharmonicbio.com THRD
